Hepatitis C inhibitor tri-peptides

Details Hepatitis C inhibitor tri-peptides Hepatitis C inhibitor tri-peptides

2006-08-15

2006-08-15

Campell, Bruce (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S312000, C530S331000, C546S153000

Reexamination Certificate

active

07091184

ABSTRACT:
Compounds of formula (I):wherein R1is hydroxyl or sulfonamide derivative; R2is t-butyl or —CH2—C(CH3)3or —CH2-cyclopentyl; R3is t-butyl or cyclohexyl and R4is cyclobutyl, cyclopentyl or cyclohexyl; or a pharmaceutically acceptable salt thereof, are described as useful as inhibitor of the HCV NS3 protease.

REFERENCES:
patent: 6159938 (2000-12-01), Gyorkos et al.
patent: 6187905 (2001-02-01), Hurst et al.
patent: 6323180 (2001-11-01), Llinas-Brunet et al.
patent: 2004/0147483 (2004-07-01), Priestley
patent: 2 337 262 (1999-11-01), None
patent: 10-298151 (1998-11-01), None
patent: 11-35478 (1999-02-01), None
patent: 11-127861 (1999-05-01), None
patent: 11-137252 (1999-05-01), None
patent: 11-292840 (1999-10-01), None
patent: 2001-103993 (2001-04-01), None
patent: WO 97/43310 (1997-11-01), None
patent: WO 98/17679 (1998-04-01), None
patent: WO 98/22496 (1998-05-01), None
patent: WO 98/46597 (1998-10-01), None
patent: WO 98/46630 (1998-10-01), None
patent: WO 99/07733 (1999-02-01), None
patent: WO 99/07734 (1999-02-01), None
patent: WO 99/38888 (1999-08-01), None
patent: WO 99/50230 (1999-10-01), None
patent: WO 99/64442 (1999-12-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09558 (2000-02-01), None
patent: WO 00/31129 (2000-02-01), None
patent: WO 00/20400 (2000-04-01), None
patent: WO 00/59929 (2000-10-01), None
patent: WO 01/02424 (2001-01-01), None
patent: WO 01/07407 (2001-02-01), None
patent: WO 01/16357 (2001-03-01), None
patent: WO 01/32691 (2001-05-01), None
patent: WO 01/40262 (2001-06-01), None
patent: WO 01/58929 (2001-08-01), None
patent: WO 01/64678 (2001-09-01), None
patent: WO 01/74768 (2001-10-01), None
patent: WO 01/77113 (2001-10-01), None
patent: WO 01/81325 (2001-11-01), None
patent: WO 02/08187 (2002-01-01), None
patent: WO 02/08198 (2002-01-01), None
patent: WO 02/08244 (2002-01-01), None
patent: WO 02/08251 (2002-01-01), None
patent: WO 02/08256 (2002-01-01), None
patent: WO 02/18369 (2002-03-01), None
patent: WO 02/060926 (2002-08-01), None
patent: WO 02/079234 (2002-10-01), None
Sibal et al. 2001, ILAR Journal, vol. 42, No. 2, pp. 74-84.
Huang, et al; “Olefin Metathesis-Active Ruthenium Complexes Bearing a Nucleophilic Carbene Ligand”; J. Am. Chem. Soc. 1999, 121, pp. 2674-2678.
Kingsbury, et al; “A Recyclable Ru-Based Metathesis Catalyst”; J. Am. Chem. Soc. 1999, 121, pp. 791-799.
Krchnak, et al; “Polymer-Supported Mitsunobu Ether Formation and its Use in Combinatorial Chemistry”; Tetrahedron Ltrs., vol. 36, No. 35, pp. 6193-6916, 1995.
Lohmann, et al; “Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line”; Science. 1999. vol. 285. pp. 110-113.
Miller, et al; “Application of Ring-Closing Metathesis to the Synthesis of Rigidified Amino Acids and Peptides”; J. Am. Chem. Soc. 1996, 118, pp. 9606-9614.
Mitsunobu; “The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products”; Synthesis (Reviews), pp. 1-28.
Rano, et al; “Solid Phase Synthesis of Aryl Ethers Via the Mitsunobu Reaction”; Tetrahedron Ltrs., 1995, vol. 36, No. 22, pp. 3789-3792.
Still, et al; “Rapid Chromatographic Technique for Preparative Separations with Moderate Resolution”; J. Org. Chem. 1978. vol. 43, No. 14, pp. 2923-2925.
Derwent Abstract: AN 2001-435746 [47] (JP2001103993).
Derwent Abstract: AN 1999-040664 [04] (JP 10298151).
Derwent Abstract: AN 1999-350322 [30] (JP 11127861).
Derwent Abstract: AN 2000-018687 [02] (JP 11292840).
Derwent Abstract AN 1999-186214 [16] (JP 11035478).
Derwent Abstract AN 1999-374374 [32] (JP 11137252).

Affiliated with

Also associated with

Rating

Hepatitis C inhibitor tri-peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis C inhibitor tri-peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C inhibitor tri-peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3630521